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incorrect p values whenever allele frequencies are
unequal. If we denote PDOST(x) as the value of PDOST asso-
ciated with sample-conﬁguration x, we can guarantee
that, under the null hypothesis of HWE, P(PDOST %
PDOST(x)) < PDOST(x) whenever allele frequencies are
unequal. In contrast, using PHWE, Plow, Phigh guarantees
a properly calibrated test statistic so that, for example,
P(PHWE % PHWE(x)) ¼ PHWE(x), regardless of allele
frequency.
A simple example is illustrative. Consider a sample of
100 individuals in whom two copies of the rare allele
are present. Two conﬁgurations are possible, one with
two heterozygotes and another with a single rare allele
homozygote. The ﬁrst conﬁguration has probability of
198/199, and the second has a probability of 1/199.
Suppose a single homozygote is observed. This gives a c2
test p value of < 1022 (without continuity correction)
or < 106 (with continuity correction). Both are clearly
wrong. Using PDOST is ‘‘better,’’ giving p ¼ 2/199, but still
incorrect. In contrast, PHWE correctly speciﬁes that a conﬁg-
uration such as this occurs with p ¼ 1/199. For rare alleles
and unlikely conﬁgurations, PDOST and P2a are effectively
equal to 2PHWE. For common alleles and large samples,
the three statistics converge to more similar values, but,
in those settings, c2 test approximations can be conve-
niently used.
The fact that PDOST and P2a detect fewer departures from
HWE is not a virtue. It simply reﬂects that they are poorly
calibrated statistics. If an investigator wishes to discard
fewer SNPs due to HWE departures, it is more appropriate
to lower a, the threshold for rejection. Just as we foundThe Ameno reason to recommend P2a originally, we ﬁnd no reason
to recommend PDOST now.
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Levels in the Developing
Mouse and Human BrainTo the Editor: Sheridan and colleagues recently reported
thatmutations in the tubulin gene TUBA8 result in polymi-
crogyria with optic nerve hypoplasia (PMGOH [MIM
613180]).1 This conclusion is based on the mapping of
two consanguineous families of Pakistani origin to a 7.42
Mb region on chromosome 22q11.2 that contains ~230
genes including TUBA8. Drawing on our previous ﬁnding
that mutations in TUBA1A cause lissencephaly2 and that
mutations in TUBB2B cause asymmetric polymicrogyria,3
Sheridan and colleagues sequenced TUBA8 and found a 14
bp deletion in intron 1 that affects splicing. They provide
further evidence that TUBA8 is involved in the disease state
by analyzing its expression in the developing mouse brain
by in situhybridization.They report thatTuba8 iswidely ex-
pressed in developing neural structures, with strongest
expression in the cortical plate at E15.5 and E18.5 and in
the cortical plate, subplate, and hippocampus at P0.Ameaningful analysis of individual tubulin gene expres-
sion by in situ hybridization requires the use of probes that
avoid cross-hybridization among the highly conserved
coding regions, relying exclusively on either the variant
50 or 30 untranslated regions. The probe employed by Sher-
idan and colleagues was 443 nucleotides in length, of
which 415 correspond to sequences contained within the
conserved coding region. Consequently, this probe shares
a very high sequence homology with other a-tubulins.4
An Ensembl BLAST search with the Sheridan probe against
total mouse cDNA results in six other hits, each being at
least 300 nucleotides in length with at least 80% sequence
identity. Each of these hits corresponds to one of the six
other members of the a-tubulin family and includes a
374 nucleotide stretch that shares 84.2% identity with the
coding sequence of Tuba1a, a gene that is highly expressed
in the developing CNS.5
To establish whether the results reported by Sheridan
and colleagues are a consequence of cross-hybridization,
we conducted in situ hybridization on the developing
(E14.5, E16.5, and P0) and adult mouse brain employing
their probe and two others that we designed. We ﬁrst
conﬁrmed the sequence of Tuba8 mRNA by amplifyingrican Journal of Human Genetics 86, 813–823, May 14, 2010 819
Figure 1. Tuba8 Expression in the Developing Mouse Brain
Coronal sections (14 mm) of the developing cortex (E14.5, E16.5,
P0) showing our in situ hybridization results obtained with the
probe employed by Sheridan and colleagues (A, D, G) and the
short (B, E, H) and long (C, F, I) probe targeted to the unique 30
UTR of Tuba8. High levels of staining are observed in the devel-
oping mouse brain with the Sheridan probe (particularly in the
cortical plate [CP] and to a lesser extent in the intermediate zone
[IZ] and ventricular zone [VZ]), but none is apparent with probes
that exclusively target the 30 UTR. We observed no staining
when employing control sense probes (data not shown). Scale
bars represent 50 mm. MZ indicates the marginal zone.and cloning it from a C57BL/6 mouse adult olfactory bulb
cDNA library (AK032157, GU591980) (Figure S1 available
online). Next we designed two probes, a short probe (224
base pairs in length [nt 1569–1792]) and a long probe
(545 base pairs in length [nt 1367–1911]) targeted to the
highly variant 30 UTR of Tuba8 (GU591980). These probes,
along with the probe employed by Sheridan, were cloned
into a pCRII-TOPO vector (Invitrogen, 45-0640), and the
sequence was conﬁrmed by Big Dye sequencing with a
3730 DNA Analyzer (Applied Biosystems). We checked the
speciﬁcity of our probes by conducting an Ensembl BLAST
search against total mouse cDNA. This revealed no other
hits that could potentially form a stable hybrid with either
our short or long UTR probes. After linearization of the
probes, a T7 or SP6 promoter-driven in vitro transcription
reaction was done in the presence of a DIG labeling mix
(Roche, 11175025910). The denatured probes (sense or
antisense) were then applied to pretreated coronal sections
and hybridized overnight in a custom-built chamber.6
Staining was visualized by incubating sections with an
alkaline phosphatase conjugated digoxygenin antibody
(1:2000, 4C, overnight) (Roche, 11093274910), followed
by the application of BM-Purple AP (Roche, 1144207400).
When we used Sheridan’s probe, we observed strong
staining at E14.5, E16.5, and P0, particularly in the cortical820 The American Journal of Human Genetics 86, 813–823, May 14,plate, and to a lesser extent in the intermediate and
ventricular zones (Figure 1). In contrast, we did not observe
any signal at any of these time points with our Tuba8
30UTR-speciﬁc probes, although we did observe positive
staining in the Purkinje cell layer in the cerebellum and
in the mitral and granule cell layers of the olfactory bulbs
in the adult brain (Figure S2).
Because there is evidence for an alternatively spliced
variant of Tuba8 with a shorter UTR, we conﬁrmed our
in situ hybridization results by undertaking real-time
quantitative PCR (qPCR) with primers targeted to the
coding region (Table S1).7 When designing intron-span-
ning primers for this task, we took care to ensure that
each primer pair was speciﬁc, undertaking BLAST searches
with multiple search engines (Ensemble, UCSC, and NCBI).
In addition, we only used primer pairs with an efﬁciency
between 95% and 105% that produced a melt curve indic-
ative of a single product. To prepare templates for ampliﬁ-
cation, we dissected and ﬂash froze embryonic brains
(E10.5 [head], E12.5, E14.5, E16.5, E18.5), postnatal brains
(P0, P6), various regions of the adult brain (8 weeks) and
adult organs (C57BL/6), prior to RNA extraction (QIAGEN,
74804, 74704). Three independent RNA samples from each
developmental time point, brain region, or organ were
then quantitated and pooled for reverse transcription (In-
vitrogen, 45-0640). Quantitative PCR followed on a BioRad
Cycler with SYBR green, alongside reverse transcriptase
(RT) and cDNA negative controls. All reactions were per-
formed in triplicate and normalized to the geometric
mean of three reference genes (Pgk1, Tfrc, and Hprt).8,9
We compared the expression of Tuba8 to those tubulin
genes (Tuba1a [MIM 611603], Tubb2b [MIM 610031],
Tubb3 [MIM 600638]) that have been shown to cause
distinct neurodevelopmental diseases.10 We found that
Tuba 1a, Tubb2b, and Tubb3 are highly expressed in the
developing mouse brain from E12.5 to P6, whereas Tuba8
is expressed at low levels (Figure 2A). For instance, at
E14.5, a peak time for neuronal migration, Tuba1a is
expressed at ~94 times the control gene level, whereas
Tuba8 is barely detectable, expressed at just 0.03 times
the control gene level. We next analyzed expression levels
of Tuba8 in different regions of the adult mouse brain by
qPCR, again comparing it to Tuba1a, Tubb2b, and Tubb3
(Figure 2B). We observed regional differences in the ex-
pression levels of these genes, but generally Tuba1a was
most highly expressed, followed by Tubb3 and Tubb2b.
Tuba8 was again expressed at very low levels, with the
exception of the olfactory bulbs and the cerebellum, where
its modest level of expression was concordant with the
results from our in situ hybridization experiments. We
extended our expression analysis beyond the adult brain
to the major adult organs in the mouse (Figure S3). We
found that the level of Tuba8 expression is highest in testis
(~12 times control gene expression), followed by skeletal
and heart muscle, conﬁrming the results of Stanchi and
colleagues who studied TUBA8 expression in adult human
tissues.72010
Figure 2. Real-Time qPCR Analysis of Tuba8 Expression Levels in Mouse and Human Brain
(A) Relative expression levels of Tuba1a, Tubb2b, Tubb3, and Tuba8 in the developing mouse brain (E10.5 [head], E12.5, E14.5, E16.5,
E18.5, P0, and P6). Tuba8 is expressed at very low levels at all developmental stages.
(B) In the adult mouse brain, there are regional expression differences when comparing Tuba1a, Tubb2b, Tubb3, and Tuba8. The expres-
sion of Tuba8 is again low, with the exception of the olfactory bulbs and cerebellum, where it is expressed at modest levels.
(C) Expression of TUBA1A, TUBB2B, TUBB3, and TUBA8 in the developing human brain at GW13 (frontal lobe) and GW22 (total fetal
brain). Again, TUBA8 is expressed at low levels. Error bars indicate the SEM.Finally, we investigated the expression of TUBA1A,
TUBB2B, TUBB3, and TUBA8 in human fetal brain at
GW13 (Biochain, C1244051) and GW22 (Biochain,
C1244035), again employing three reference genes for
normalization (HPRT, PGK1, TBP). Consistent with our
mouse data, we observed very high levels of expression of
TUBA1A, TUBB2B, and TUBB3, but only low levels of
TUBA8 (Figure 2C). For instance, in the frontal lobe at
GW13, a peak time for neuronal migration in humans,11
expression of TUBA1A is ~224 times the control level,
whereas TUBA8 is expressed at just 0.18 times the control
gene level. We replicated our qPCR results with alternative
sets of primers (in both mouse and human), conﬁrming
that our qPCR results are not due to alternative splicing
(data not shown).
The data presented here show that Tuba8 is expressed at
a low level in the developing mouse and human brain.
This raises a puzzling question: How is it that a gene that
is preferentially expressed in testis, heart, and skeletal
muscle presents as a rare brain malformation? This ques-
tion is particularly pertinent given that those tubulin
genes known to cause neurodevelopmental disorders are
highly expressed in the developing CNS, whereas Tuba8
is not. We suggest three possible explanations. First, it is
plausible that an unidentiﬁed mutation lies in one of the
230 unsequenced genes in the 7.42 Mb candidate intervalThe Amethat contributes to, or is responsible for, the observed
phenotype. Second, it is conceivable that despite its low
expression level, Tuba8 serves some unique function that
is essential to the developing brain and that is not vital
in other tissues. Third, one might imagine a scenario in
which the deletion described by Sheridan results in the
expression of a truncated tubulin polypeptide and that
this might confer some deleterious effect. The generation
of appropriate transgenic mouse models or the identiﬁca-
tion of additional genetically unrelated patients harboring
mutations in TUBA8 would help to resolve these issues.
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To the Editor: We note with interest the discordance
between the TUBA8 (MIM 605742) expression data ob-
tained by Keays et al. and those we previously presented.1
We accept that there is a possibility of cross-hybridization
of the probes we used with other members of the a-tubulin
family.
We suggest, however, that the tissue distribution of
expression in the adult animal is of limited relevance
when considering the pathogenesis of a neurodevelopmen-
tal phenotype. The high level of expression of TUBA8 in
the adult testis has been previously noted. Although this
may imply a speciﬁc role of TUBA8 in spermatogenesis, it
does not imply the absence of an important role elsewhere.
(We would also point out that the severe disability of the
patients with homozygous TUBA8 mutations precludes
any knowledge concerning their fertility or testicular
histology.)
Keays et al. also draw a contrast between low brain
expression of TUBA8 they observe and the much greater
expression of TUBA1A (MIM 602529) and TUBB2B (MIM
612850), previously shown to be mutated in neurodeve-
lopmental disorders. However, such a comparison impliesvery little, given that the disease-causing TUBA1A and
TUBB2B mutations are de novo dominants, in contrast to
the autosomal-recessive inheritance in our families.
There are many examples of apparent discordance
between patterns of tissue-speciﬁc gene expression and the
phenotype manifested when a gene is mutated. In some
cases, these may reﬂect differential sensitivity of tissues
to loss of gene product; neural tissues are notable in this
regard. Mutations in the genes encoding the globally
expressed pre-mRNA splicing factors PRPF8 (MIM 607300)
and PRPF31 (MIM 606419), for example, result in a highly
tissue-speciﬁc phenotype (retinitis pigmentosa) but no
discernable phenotypic effects in other tissues in which
they are highly expressed.2 Similarly, the distinctive neuro-
developmental phenotype, Rett syndrome, results from
mutationof a ubiquitously expressedDNAbindingprotein,
MeCP2 (MIM 300005).3 Other highly speciﬁc phenotypes
associated with mutations of widely expressed genes
include motor neuron disease (SOD1 [MIM 147450])4 and
a-thalassaemia mental retardation (ATRX [MIM 300032]).5
In the patients we described, almost all TUBA8 tran-
scripts are aberrantly spliced as a result of the 14 bp
polypyrimidine tract mutation, in both lymphoblastoid
cells and ﬁbroblasts (unpublished data). The phenotype2010
